The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma.
 
Erel Joffe
Consulting or Advisory Role - AstraZeneca
 
Santosha Adipudi Vardhana
Honoraria - Agios
Consulting or Advisory Role - ADC Therapeutics; Immunai
 
Anita Kumar
No Relationships to Disclose
 
Mehrdad Abedi
No Relationships to Disclose
 
Rasmus Hoeg
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Anas Younes
Honoraria - Abbvie; Curis; Epizyme; Janssen; Merck; Roche; Takeda
Consulting or Advisory Role - Bio-Path Holdings, Inc; Celgene; Epizyme; HCM; Roche; Xynomic Pharma
Research Funding - Bristol-Myers Squibb (Inst); Curis (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst); Roche (Inst); Syndax (Inst)